The advent of novel nonsteroidal mineralocorticoid receptor antagonists in heart failure - PACE-CME

The advent of novel nonsteroidal mineralocorticoid receptor antagonists in heart failure

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Beneficial effects of MRAs in HF across the LVEF spectrum
Beneficial effects of MRAs in HF across the LVEF spectrum
ESC Congress 2024
Beneficial effects of MRAs in HF across the LVEF spectrum
- Pardeep Jhund, MD, PhD
Disease-modifying effects of finerenone in CKM syndrome
Disease-modifying effects of finerenone in CKM syndrome
ESC Congress 2024
Disease-modifying effects of finerenone in CKM syndrome
- Muthiah Vaduganathan, MD
Remarkable results in phase 3 study with vutrisiran in patients with ATTR-CM
Remarkable results in phase 3 study with vutrisiran in patients with ATTR-CM
ESC Congress 2024
Remarkable results in phase 3 study with vutrisiran in patients with ATTR-CM
- Marianna Fontana, MD, PhD
MinuteCE®
Early intervention & long-term success: Navigating hyperkalemia in cardiorenal disease
0.75 credits 3 episodes
- Gianluigi Savarese, MD
- Aaron Wong, MD
- James Burton, MD
- Clara Bonanad Lozano, MD, PhD
0.75 credits 3 episodes